Medine.co.uk

Out of date information, search another

Naratriptan 2.5mg Tablets

Out of date information, search another
Informations for option: Naratriptan 2.5mg Tablets, show other option
Document: document 0 change

NARAMIG® 2.5mg TABLETS/NARATRIPTAN 2.5mg TABLETS (naratriptan hydrochloride)

Patient Information Leaflet

This


product is available as the above names but will be referred to as Naramig throughout this leaflet.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist.

•    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

•    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1.    What Naramig is and what it is used for

2.    What you need to know before you take Naramig

3.    How to take Naramig

4.    Possible side effects

5.    How to store Naramig

6.    Contents of the pack and other information

1. What Naramig is and what it is used for

Naramig tablets contain naratriptan (hydrochloride), which belongs to a group of medicines called triptans (also known as 5-HTi receptor agonists).

Naramig tablets are used to treat migraine.

Migraine symptoms may be caused by the temporary widening of blood vessels in the head.

Naramig tablets are believed to reduce the widening of these blood vessels. This in turn helps to take away the headache and relieve other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and sensitivity to light and sound.

2. What you need to know before you take Naramig

Do not take Naramig:

   If you are allergic to naratriptan, or any of the other ingredients of this medicine (listed in section 6)

   If you have a heart problem such as heart failure or chest pains (angina), or have already had a heart attack

   If you have circulation problems in your legs that cause cramp-like pains when you walk (peripheral vascular disease)

   If you have had a stroke or a mini-stroke (also called a transient ischaemic attack or TIA)

   If you have high blood pressure. You may be able to take Naramig if your high blood pressure is mild and is being treated.

   If you have kidney or liver disease

   With other migraine medicines, including those which contain ergotamine, or with similar medicines such as methysergide, or with other 5-HTi receptor agonists, such as sumatriptan.

If any of these apply to you:

•    Tell your doctor, and don't take Naramig.

Warnings and precautions

Talk to your doctor or pharmacist before taking Naramig.

If you have any extra risk factors

•    If you are a heavy smoker or are using nicotine replacement therapy, and especially

   If you are a man over 40, or

•    If you are a woman who has been through the menopause.

In very rare cases, people have developed serious heart conditions after taking Naramig, even though they had no signs of heart disease before.

If any of the points in the list applies to you, it could mean you have a greater risk of developing heart disease - so:

•    Tell your doctor so that your heart function can be checked before Naramig is prescribed for you.

If you are allergic to antibiotics called sulphonamides

If so, you may also be allergic to Naramig. If you know you are allergic to an antibiotic but you are not sure whether it is a sulphonamide:

•    Tell your doctor or pharmacist before taking Naramig.

If you take Naramig frequently

Taking Naramig too often may make your headaches worse.

•    Tell your doctor if this applies to you. He or she may recommend you stop taking Naramig.

If you feel pain or tightness in your chest after you take Naramig

These effects may be intense but they usually pass quickly. If they don't pass quickly, or they become severe:

•    Get medical help immediately. Section 4 of this leaflet has more information about these possible side effects.

Not for older people or children under 18

Naramig is not recommended for people aged over 65 or for children under the age of 18.

Other medicines and Naramig

Tell your doctor if you're taking, have recently taken or might take any other medicines.

Some medicines must not be taken with Naramig and others may cause adverse effects if they're taken with Naramig. You must tell your doctor if you are taking:

•    any medicines for your migraine which contain any triptan/5-HT1 agonist (such as sumatriptan or zolmitriptan). Don't take Naramig at the same time as these medicines. Stop taking these medicines at least 24 hours before taking Naramig.

   ergotamine also used to treat migraine or similar medicines such as methysergide. Don't take Naramig at the same time as these medicines. Stop taking these medicines at least 24 hours before taking Naramig.

•    any antidepressants classed as selective serotonin reuptake inhibitors (SSRIs), such as citalopram, fluoxetine or paroxetine, or serotonin noradrenaline reuptake inhibitors (SNRIs) such as venlafaxine. If you are not sure, talk to your doctor or pharmacist.

•    St John's Wort (Hypericum perforatum). Using herbal remedies that contain St John's Wort while you are taking Naramig may make side effects more likely.

Pregnancy and breast-feeding

•    If you are pregnant, think you may be pregnant or are planning to have a baby ask your

doctor for advice before taking this medicine. There is only limited information about the safety of Naramig for pregnant women, though up till now there is no evidence of any increased risk of birth defects. Your doctor may recommend that you do not take Naramig while you are pregnant.

•    Don't breast-feed your baby for 24 hours after taking Naramig. If you express any breast milk during this time, discard the milk and don't give it to your baby.

Driving and using machines

•    Either the symptoms of migraine or your medicine may make you drowsy. If you are affected, don't drive or operate machinery.

Naramig contains lactose

Naramig tablets contain a small amount of a sugar called lactose. If you have an intolerance to lactose or any other sugars:

Ask your doctor for advice about taking Naramig.

f

Only take Naramig after your migraine headache begins. Don't take Naramig to try to prevent an attack.

Always take this medicine exactly as your doctor has told you.

Check with your doctor or pharmacist if you are not sure.

How much to take

•    The usual dose for adults aged 18 to 65 is one Naramig 2.5 mg tablet, swallowed whole with water.

Naramig is not recommended for children under 18 and adults over 65.

When to take Naramig

   It's best to take Naramig as soon as you feel a migraine coming on, although it can be taken at any time during an attack.

If your symptoms start to come back

•    You can take a second Naramig tablet after 4 hours, unless you have kidney or liver damage.

   If you have kidney or liver damage don't take more than one tablet in 24 hours.

   No one should take more than two tablets in 24 hours.

If the first tablet has no effect

   Don't take a second tablet for the same attack.

If Naramig doesn't give you any relief:

   Ask your doctor or pharmacist for advice.

If you take more Naramig than you should

   Don't take more than two Naramig tablets in 24 hours.

Taking too much Naramig could make you ill. If you have taken more than two tablets in 24 hours:

   Contact your doctor for advice.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:

   Heartbeat may go faster, slower or change rhythm (affects up to 1 in 100 people).

   Pain in the lower left side of the stomach and bloody diarrhoea (ischaemic colitis - affects up to 1 in 1,000 people).

   Allergic reaction (affects up to 1 in 1,000 people). The signs of allergy include rash; wheezing; swollen eyelids, face or lips; complete collapse.

If you get any of these symptoms soon after taking Naramig:

•    Don't take any more. Contact a doctor straight away.

•    Heaviness, pressure, tightness or pain in the chest, throat or other parts of the body (affects up to 1 in 100 people).

These effects may be intense but generally pass quickly.

If these effects continue or become severe (especially the chest pain):

   Get medical help urgently. In a very small number of people these symptoms can be caused by a heart attack.

Common:

may affect up to 1 in 10 people

•    Feeling sick (nausea) or being sick (vomiting), although this may be due to the migraine itself.

Tiredness, drowsiness, or generally feeling unwell.

•    Dizziness, tingling feelings or getting hot flushes.

If you get any of these effects:

•    Tell your doctor or pharmacist.

Uncommon:

may affect up to 1 in 100 people

•    Visual disturbances (although these may be due to the migraine attack itself).

•    Slight increase in blood pressure which may occur up to 12 hours after taking Naramig.

If you get any of these effects:

   Tell your doctor or pharmacist.

Very rare:

may affect up to 1 in 10,000 people

•    Heart problems, including chest pains (angina) and heart attack.

•    Poor blood circulation to the arms and legs, causing pain and discomfort.

If you get these symptoms:

•    Tell your doctor or pharmacist.

If you get side effects

If you notice any unwanted effects, even ones not listed in this leaflet, or if any of the side effects becomes troublesome:

   Tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Naramig

•    Naramig 2.5mg tablets/Naratriptan 2.5mg tablets should be stored below 30°C.

•    KEEP ALL MEDICINES OUT OF THE SIGHT AND REACH OF CHILDREN.

•    Do not use after the expiry date printed on the carton, label or blister strip.

•    If your doctor tells you to stop taking the tablets, please take them back to the pharmacist for safe disposal. Only keep the tablets if your doctor tells you to.

•    If the tablets become discoloured or show any other signs of deterioration, seek the advice of your pharmacist before taking them.

•    If you have any unwanted Naramig, don't dispose of it in your waste water or household rubbish. Take it back to your pharmacist who will dispose of it in a way that won't harm the environment.

6. Contents of the pack and other information

Your medicine is called Naramig 2.5mg tablets/Naratriptan 2.5mg tablets.

Each green D-shaped oblong film coated tablet contains 2.5mg of the active ingredient naratriptan, (as the hydrochloride) and is marked ‘GX CE5' on one face.

Naramig 2.5mg tablets/Naratriptan 2.5mg tablets contain the following:

lactose anhydrous, microcrystalline cellulose, sodium croscarmellose, magnesium stearate, hypromellose, titanium dioxide (E171), triacetin, indigo carmine (E132) and yellow iron oxide (E172).

Naramig 2.5mg tablets/Naratriptan 2.5mg tablets are available as blister packs of 6 and 12 tablets.

Additional information

This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist who have the information you need, and will advise you.

POM


PL No: 6464/0981

This product is manufactured by GlaxoSmithKline Pharmaceuticals S.A. ul, Grunwaldzka 189, 60-322 Poznan, Poland and Glaxo Wellcome Operations UK Ltd, Ware, England and is procured from within the EU and repackaged by the Product Licence holder:

Waymade plc, Miles Gray Road, Basildon, Essex SS14 3FR

Leaflet revision and issue date (Ref.) 30.10.2013 Naramig is a registered trademark of GLAXO GROUP Ltd